Article

Hypertension Drugs and Skin Cancer Risk Highlights SPT Week in Review

Author(s):

Top news of the week from Specialty Pharmacy Times.

5. Millennials Rely on Internet for Information, Providers for Cancer Treatment Decisions

Patients with cancer and caregivers said that the internet helped them to make informed care-related decisions. Read more.

4. PBM Acquisition Allows Diplomat Pharmacy Inc. to Expand Patient-Centric Offerings

Diplomat Pharmacy Inc.’s Acquisition of National Pharmaceutical Services will improve patient management services. Read more.

3. Tisagenlecleucel Elicits Complete Response in Diffuse Large B-Cell Lymphoma Patients

Tisagenlecleucel (Kymriah) produced an overall response rate of 53% in patients with lymphoma. Read more.

2. No Relief from High Drug Costs in Sight

Prescription drug list prices outpaced the rate of inflation every year from 2006 to 2015. Read more.

1. Anti-Hypertensives May Increase the Risk of Skin Cancer

Patients taking hydrochlorothiazide may be 7 times more likely to develop squamous cell carcinoma. Read more.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
World Standards Week 2024: US Pharmacopeia’s Achievements and Future Focus in Pharmacy Standards